SCHEMBL20150700

SCHEMBL20150700

COc1cccc(C=O)c1OCC(=O)NS(C)(=O)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.51
▸ NFE2L2 Q16236 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ TLR2 O60603 1/20 0.44
▸ ERN1 O75460 1/20 0.44
▸ TLR1 Q15399 1/20 0.44
▸ TLR6 Q9Y2C9 1/20 0.44
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150987 0.87 SRC (0.48) SRCNFE2L2TSHRHTTNPC1
SCHEMBL20150988 0.84 SRC (0.56) SRCNFE2L2NPC1RAB9ATLR2
SCHEMBL2555240 0.84 SRC (0.56) SRCNFE2L2TSHRHTTNPC1
SCHEMBL29952197 0.82 ALDH1A1 (0.56) SRCNFE2L2TSHRHTTNPC1
SCHEMBL2553815 0.81 SRC (0.52) SRCNFE2L2NPC1RAB9ATLR2
SCHEMBL29954418 0.81 POLB (0.57) SRCNFE2L2NPC1RAB9ATLR2
SCHEMBL2555444 0.81 SRC (0.52) SRCNFE2L2TSHRHTTNPC1
SCHEMBL2556798 0.80 HSD17B10 (0.53) SRCNFE2L2TSHRHTTNPC1
SCHEMBL2554736 0.80 PTGDR2 (0.62) SRCNFE2L2NPC1RAB9ATLR2
SCHEMBL2554954 0.79 SRC (0.50) SRCNFE2L2HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2021-07-29 — — US disclosed
US-20180134667-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 SRC 3807/4885NFE2L2 634/4885TSHR 4829/4885
US-20180134667-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 SRC 3807/4885NFE2L2 634/4885TSHR 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback